Yüklüyor......
Overview of Biomarkers and Surrogate Endpoints in Drug Development
There are numerous factors that recommend the use of biomarkers in drug development including the ability to provide a rational basis for selection of lead compounds, as an aid in determining or refining mechanism of action or pathophysiology, and the ability to work towards qualification and use of...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
IOS Press
2002
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3851644/ https://ncbi.nlm.nih.gov/pubmed/12364809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2002/929274 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|